nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.201	0.368	CbGaD
Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.108	0.197	CbGaD
Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.0979	0.18	CbGaD
Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.0827	0.152	CbGaD
Clomipramine—ALB—chronic obstructive pulmonary disease	0.0566	0.104	CbGaD
Clomipramine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0275	0.111	CbGbCtD
Clomipramine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0275	0.111	CbGbCtD
Clomipramine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0216	0.0871	CbGbCtD
Clomipramine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0209	0.0844	CbGbCtD
Clomipramine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0209	0.0844	CbGbCtD
Clomipramine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0186	0.0752	CbGbCtD
Clomipramine—ALB—Prednisone—chronic obstructive pulmonary disease	0.0178	0.0719	CbGbCtD
Clomipramine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0175	0.0708	CbGbCtD
Clomipramine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0119	0.0478	CbGbCtD
Clomipramine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0466	CbGbCtD
Clomipramine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0113	0.0456	CbGbCtD
Clomipramine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0101	0.0407	CbGbCtD
Clomipramine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00987	0.0398	CbGbCtD
Clomipramine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00932	0.0376	CbGbCtD
Clomipramine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00591	0.0239	CbGbCtD
Clomipramine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00567	0.305	CbGeAlD
Clomipramine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00559	0.0225	CbGbCtD
Clomipramine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00206	0.111	CbGeAlD
Clomipramine—GSTP1—respiratory system—chronic obstructive pulmonary disease	0.000786	0.0423	CbGeAlD
Clomipramine—GSTP1—connective tissue—chronic obstructive pulmonary disease	0.000692	0.0372	CbGeAlD
Clomipramine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000654	0.0352	CbGeAlD
Clomipramine—GSTP1—bronchus—chronic obstructive pulmonary disease	0.000647	0.0348	CbGeAlD
Clomipramine—GSTP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000633	0.0341	CbGeAlD
Clomipramine—GSTP1—trachea—chronic obstructive pulmonary disease	0.000581	0.0313	CbGeAlD
Clomipramine—HRH2—lung—chronic obstructive pulmonary disease	0.000579	0.0312	CbGeAlD
Clomipramine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000576	0.031	CbGeAlD
Clomipramine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000522	0.0281	CbGeAlD
Clomipramine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000442	0.0238	CbGeAlD
Clomipramine—GSTP1—lung—chronic obstructive pulmonary disease	0.000417	0.0225	CbGeAlD
Clomipramine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000358	0.0193	CbGeAlD
Clomipramine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000347	0.0187	CbGeAlD
Clomipramine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000346	0.0186	CbGeAlD
Clomipramine—HTR2B—lung—chronic obstructive pulmonary disease	0.000344	0.0185	CbGeAlD
Clomipramine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000335	0.018	CbGeAlD
Clomipramine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000306	0.0165	CbGeAlD
Clomipramine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000305	0.0164	CbGeAlD
Clomipramine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000301	0.0162	CbGeAlD
Clomipramine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000279	0.015	CbGeAlD
Clomipramine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000256	0.0138	CbGeAlD
Clomipramine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000235	0.0126	CbGeAlD
Clomipramine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000227	0.0122	CbGeAlD
Clomipramine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000216	0.0116	CbGeAlD
Clomipramine—HTR2A—lung—chronic obstructive pulmonary disease	0.000184	0.00989	CbGeAlD
Clomipramine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000168	0.00902	CbGeAlD
Clomipramine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.00015	0.0445	CrCbGaD
Clomipramine—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000127	0.0377	CrCbGaD
Clomipramine—ABCB1—lung—chronic obstructive pulmonary disease	0.00012	0.00648	CbGeAlD
Clomipramine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.0326	CrCbGaD
Clomipramine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	9.88e-05	0.000731	CcSEcCtD
Clomipramine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	9.87e-05	0.00073	CcSEcCtD
Clomipramine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	9.86e-05	0.00073	CcSEcCtD
Clomipramine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	9.86e-05	0.00073	CcSEcCtD
Clomipramine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	9.83e-05	0.000727	CcSEcCtD
Clomipramine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	9.78e-05	0.000724	CcSEcCtD
Clomipramine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000723	CcSEcCtD
Clomipramine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	9.76e-05	0.000722	CcSEcCtD
Clomipramine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	9.74e-05	0.00072	CcSEcCtD
Clomipramine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	9.66e-05	0.000715	CcSEcCtD
Clomipramine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	9.65e-05	0.0286	CrCbGaD
Clomipramine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.000712	CcSEcCtD
Clomipramine—Oedema—Salbutamol—chronic obstructive pulmonary disease	9.59e-05	0.000709	CcSEcCtD
Clomipramine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	9.59e-05	0.000709	CcSEcCtD
Clomipramine—Hypotension—Formoterol—chronic obstructive pulmonary disease	9.49e-05	0.000702	CcSEcCtD
Clomipramine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	9.49e-05	0.000702	CcSEcCtD
Clomipramine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	9.44e-05	0.000698	CcSEcCtD
Clomipramine—Shock—Salbutamol—chronic obstructive pulmonary disease	9.43e-05	0.000698	CcSEcCtD
Clomipramine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	9.43e-05	0.0279	CrCbGaD
Clomipramine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	9.42e-05	0.000697	CcSEcCtD
Clomipramine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	9.4e-05	0.000696	CcSEcCtD
Clomipramine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000695	CcSEcCtD
Clomipramine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	9.36e-05	0.000692	CcSEcCtD
Clomipramine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000692	CcSEcCtD
Clomipramine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	9.32e-05	0.0276	CrCbGaD
Clomipramine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	9.31e-05	0.000689	CcSEcCtD
Clomipramine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	9.28e-05	0.0275	CrCbGaD
Clomipramine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	9.27e-05	0.000686	CcSEcCtD
Clomipramine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	9.27e-05	0.000686	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	9.25e-05	0.000684	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	9.25e-05	0.000684	CcSEcCtD
Clomipramine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	9.19e-05	0.000679	CcSEcCtD
Clomipramine—Insomnia—Formoterol—chronic obstructive pulmonary disease	9.19e-05	0.000679	CcSEcCtD
Clomipramine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	9.14e-05	0.000676	CcSEcCtD
Clomipramine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	9.13e-05	0.000675	CcSEcCtD
Clomipramine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	9.09e-05	0.000672	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	9.06e-05	0.00067	CcSEcCtD
Clomipramine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	9.05e-05	0.00067	CcSEcCtD
Clomipramine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	9.05e-05	0.00067	CcSEcCtD
Clomipramine—Somnolence—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000668	CcSEcCtD
Clomipramine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000668	CcSEcCtD
Clomipramine—Insomnia—Montelukast—chronic obstructive pulmonary disease	9e-05	0.000666	CcSEcCtD
Clomipramine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	8.97e-05	0.000663	CcSEcCtD
Clomipramine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	8.96e-05	0.000663	CcSEcCtD
Clomipramine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	8.94e-05	0.000661	CcSEcCtD
Clomipramine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	8.94e-05	0.000661	CcSEcCtD
Clomipramine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	8.93e-05	0.000661	CcSEcCtD
Clomipramine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	8.9e-05	0.000659	CcSEcCtD
Clomipramine—Somnolence—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000654	CcSEcCtD
Clomipramine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	8.82e-05	0.000653	CcSEcCtD
Clomipramine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	8.8e-05	0.000651	CcSEcCtD
Clomipramine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	8.78e-05	0.026	CrCbGaD
Clomipramine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	8.77e-05	0.000649	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	8.77e-05	0.000649	CcSEcCtD
Clomipramine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	8.76e-05	0.000648	CcSEcCtD
Clomipramine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	8.76e-05	0.000648	CcSEcCtD
Clomipramine—Fatigue—Formoterol—chronic obstructive pulmonary disease	8.76e-05	0.000648	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	8.74e-05	0.000646	CcSEcCtD
Clomipramine—Pain—Arformoterol—chronic obstructive pulmonary disease	8.68e-05	0.000642	CcSEcCtD
Clomipramine—Constipation—Formoterol—chronic obstructive pulmonary disease	8.68e-05	0.000642	CcSEcCtD
Clomipramine—Pain—Formoterol—chronic obstructive pulmonary disease	8.68e-05	0.000642	CcSEcCtD
Clomipramine—Constipation—Arformoterol—chronic obstructive pulmonary disease	8.68e-05	0.000642	CcSEcCtD
Clomipramine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	8.67e-05	0.000642	CcSEcCtD
Clomipramine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.00064	CcSEcCtD
Clomipramine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	8.61e-05	0.000637	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	8.59e-05	0.000635	CcSEcCtD
Clomipramine—Fatigue—Montelukast—chronic obstructive pulmonary disease	8.58e-05	0.000634	CcSEcCtD
Clomipramine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	8.55e-05	0.000632	CcSEcCtD
Clomipramine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.000631	CcSEcCtD
Clomipramine—Pain—Montelukast—chronic obstructive pulmonary disease	8.51e-05	0.000629	CcSEcCtD
Clomipramine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	8.5e-05	0.000629	CcSEcCtD
Clomipramine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	8.49e-05	0.0252	CrCbGaD
Clomipramine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	8.48e-05	0.000628	CcSEcCtD
Clomipramine—Desipramine—ADRB2—chronic obstructive pulmonary disease	8.45e-05	0.0251	CrCbGaD
Clomipramine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.000625	CcSEcCtD
Clomipramine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.000625	CcSEcCtD
Clomipramine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	8.44e-05	0.000624	CcSEcCtD
Clomipramine—Purpura—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000624	CcSEcCtD
Clomipramine—Rash—Aminophylline—chronic obstructive pulmonary disease	8.41e-05	0.000622	CcSEcCtD
Clomipramine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	8.41e-05	0.000622	CcSEcCtD
Clomipramine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	8.38e-05	0.00062	CcSEcCtD
Clomipramine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	8.37e-05	0.000619	CcSEcCtD
Clomipramine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	8.37e-05	0.000619	CcSEcCtD
Clomipramine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	8.37e-05	0.0248	CrCbGaD
Clomipramine—Headache—Aminophylline—chronic obstructive pulmonary disease	8.36e-05	0.000618	CcSEcCtD
Clomipramine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	8.34e-05	0.000617	CcSEcCtD
Clomipramine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000616	CcSEcCtD
Clomipramine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	8.32e-05	0.000616	CcSEcCtD
Clomipramine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	8.3e-05	0.000614	CcSEcCtD
Clomipramine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	8.3e-05	0.000614	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.28e-05	0.000612	CcSEcCtD
Clomipramine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	8.27e-05	0.000612	CcSEcCtD
Clomipramine—Pain—Salbutamol—chronic obstructive pulmonary disease	8.2e-05	0.000607	CcSEcCtD
Clomipramine—Constipation—Salbutamol—chronic obstructive pulmonary disease	8.2e-05	0.000607	CcSEcCtD
Clomipramine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	8.19e-05	0.0243	CrCbGaD
Clomipramine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	8.13e-05	0.000602	CcSEcCtD
Clomipramine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000602	CcSEcCtD
Clomipramine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000602	CcSEcCtD
Clomipramine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	8.07e-05	0.000597	CcSEcCtD
Clomipramine—Urticaria—Formoterol—chronic obstructive pulmonary disease	8.07e-05	0.000597	CcSEcCtD
Clomipramine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	8.03e-05	0.000594	CcSEcCtD
Clomipramine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	8.03e-05	0.000594	CcSEcCtD
Clomipramine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	8.03e-05	0.000594	CcSEcCtD
Clomipramine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	8.03e-05	0.000594	CcSEcCtD
Clomipramine—Affect lability—Prednisone—chronic obstructive pulmonary disease	8e-05	0.000592	CcSEcCtD
Clomipramine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	8e-05	0.000592	CcSEcCtD
Clomipramine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000587	CcSEcCtD
Clomipramine—Rash—Tiotropium—chronic obstructive pulmonary disease	7.93e-05	0.000587	CcSEcCtD
Clomipramine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	7.93e-05	0.000586	CcSEcCtD
Clomipramine—Nausea—Aminophylline—chronic obstructive pulmonary disease	7.93e-05	0.000586	CcSEcCtD
Clomipramine—Urticaria—Montelukast—chronic obstructive pulmonary disease	7.9e-05	0.000585	CcSEcCtD
Clomipramine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	7.9e-05	0.000585	CcSEcCtD
Clomipramine—Headache—Tiotropium—chronic obstructive pulmonary disease	7.88e-05	0.000583	CcSEcCtD
Clomipramine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	7.88e-05	0.000583	CcSEcCtD
Clomipramine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	7.86e-05	0.000582	CcSEcCtD
Clomipramine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	7.86e-05	0.000582	CcSEcCtD
Clomipramine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	7.84e-05	0.00058	CcSEcCtD
Clomipramine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	7.81e-05	0.0232	CrCbGaD
Clomipramine—Irritability—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000574	CcSEcCtD
Clomipramine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000572	CcSEcCtD
Clomipramine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	7.71e-05	0.0229	CrCbGaD
Clomipramine—Mood swings—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.00057	CcSEcCtD
Clomipramine—Desipramine—SLC6A4—chronic obstructive pulmonary disease	7.68e-05	0.0228	CrCbGaD
Clomipramine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	7.62e-05	0.0226	CrCbGaD
Clomipramine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	7.62e-05	0.000564	CcSEcCtD
Clomipramine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	7.59e-05	0.0225	CrCbGaD
Clomipramine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	7.58e-05	0.000561	CcSEcCtD
Clomipramine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	7.58e-05	0.000561	CcSEcCtD
Clomipramine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.0223	CrCbGaD
Clomipramine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	7.48e-05	0.000553	CcSEcCtD
Clomipramine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	7.48e-05	0.000553	CcSEcCtD
Clomipramine—Nausea—Tiotropium—chronic obstructive pulmonary disease	7.47e-05	0.000553	CcSEcCtD
Clomipramine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	7.46e-05	0.000552	CcSEcCtD
Clomipramine—Dry skin—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000551	CcSEcCtD
Clomipramine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	7.4e-05	0.000547	CcSEcCtD
Clomipramine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	7.33e-05	0.000542	CcSEcCtD
Clomipramine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	7.3e-05	0.0216	CrCbGaD
Clomipramine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	7.29e-05	0.000539	CcSEcCtD
Clomipramine—Asthenia—Formoterol—chronic obstructive pulmonary disease	7.29e-05	0.000539	CcSEcCtD
Clomipramine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	7.19e-05	0.000532	CcSEcCtD
Clomipramine—Pruritus—Formoterol—chronic obstructive pulmonary disease	7.19e-05	0.000532	CcSEcCtD
Clomipramine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	7.17e-05	0.000531	CcSEcCtD
Clomipramine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	7.17e-05	0.0212	CrCbGaD
Clomipramine—Asthenia—Montelukast—chronic obstructive pulmonary disease	7.14e-05	0.000528	CcSEcCtD
Clomipramine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	7.07e-05	0.000523	CcSEcCtD
Clomipramine—Pruritus—Montelukast—chronic obstructive pulmonary disease	7.04e-05	0.000521	CcSEcCtD
Clomipramine—Desipramine—CYP1A2—chronic obstructive pulmonary disease	6.99e-05	0.0207	CrCbGaD
Clomipramine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	6.95e-05	0.000514	CcSEcCtD
Clomipramine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	6.95e-05	0.000514	CcSEcCtD
Clomipramine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	6.92e-05	0.000512	CcSEcCtD
Clomipramine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	6.91e-05	0.0205	CrCbGaD
Clomipramine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	6.88e-05	0.000509	CcSEcCtD
Clomipramine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000506	CcSEcCtD
Clomipramine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	6.81e-05	0.000503	CcSEcCtD
Clomipramine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	6.78e-05	0.000502	CcSEcCtD
Clomipramine—Promazine—CYP1A2—chronic obstructive pulmonary disease	6.77e-05	0.0201	CrCbGaD
Clomipramine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	6.75e-05	0.02	CrCbGaD
Clomipramine—Dizziness—Formoterol—chronic obstructive pulmonary disease	6.72e-05	0.000497	CcSEcCtD
Clomipramine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	6.72e-05	0.000497	CcSEcCtD
Clomipramine—Acepromazine—ALB—chronic obstructive pulmonary disease	6.6e-05	0.0196	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	6.6e-05	0.0195	CrCbGaD
Clomipramine—Dizziness—Montelukast—chronic obstructive pulmonary disease	6.58e-05	0.000487	CcSEcCtD
Clomipramine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	6.56e-05	0.000485	CcSEcCtD
Clomipramine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	6.51e-05	0.0193	CrCbGaD
Clomipramine—Promethazine—HTR2A—chronic obstructive pulmonary disease	6.5e-05	0.0193	CrCbGaD
Clomipramine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000479	CcSEcCtD
Clomipramine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	6.47e-05	0.0192	CrCbGaD
Clomipramine—Vomiting—Formoterol—chronic obstructive pulmonary disease	6.46e-05	0.000478	CcSEcCtD
Clomipramine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	6.46e-05	0.000478	CcSEcCtD
Clomipramine—Thioproperazine—ALB—chronic obstructive pulmonary disease	6.45e-05	0.0191	CrCbGaD
Clomipramine—Doxepin—HTR2A—chronic obstructive pulmonary disease	6.43e-05	0.0191	CrCbGaD
Clomipramine—Diazepam—CYP1A2—chronic obstructive pulmonary disease	6.42e-05	0.019	CrCbGaD
Clomipramine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	6.41e-05	0.019	CrCbGaD
Clomipramine—Rash—Arformoterol—chronic obstructive pulmonary disease	6.4e-05	0.000474	CcSEcCtD
Clomipramine—Rash—Formoterol—chronic obstructive pulmonary disease	6.4e-05	0.000474	CcSEcCtD
Clomipramine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	6.4e-05	0.000473	CcSEcCtD
Clomipramine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	6.4e-05	0.000473	CcSEcCtD
Clomipramine—Weight increased—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000473	CcSEcCtD
Clomipramine—Headache—Arformoterol—chronic obstructive pulmonary disease	6.36e-05	0.000471	CcSEcCtD
Clomipramine—Headache—Formoterol—chronic obstructive pulmonary disease	6.36e-05	0.000471	CcSEcCtD
Clomipramine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.00047	CcSEcCtD
Clomipramine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	6.35e-05	0.00047	CcSEcCtD
Clomipramine—Pipotiazine—ALB—chronic obstructive pulmonary disease	6.35e-05	0.0188	CrCbGaD
Clomipramine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	6.34e-05	0.000469	CcSEcCtD
Clomipramine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000469	CcSEcCtD
Clomipramine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	6.34e-05	0.0188	CrCbGaD
Clomipramine—Vomiting—Montelukast—chronic obstructive pulmonary disease	6.32e-05	0.000468	CcSEcCtD
Clomipramine—Rash—Montelukast—chronic obstructive pulmonary disease	6.27e-05	0.000464	CcSEcCtD
Clomipramine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	6.27e-05	0.000464	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	6.25e-05	0.000463	CcSEcCtD
Clomipramine—Depression—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000462	CcSEcCtD
Clomipramine—Headache—Montelukast—chronic obstructive pulmonary disease	6.23e-05	0.000461	CcSEcCtD
Clomipramine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000457	CcSEcCtD
Clomipramine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000454	CcSEcCtD
Clomipramine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000454	CcSEcCtD
Clomipramine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.1e-05	0.000451	CcSEcCtD
Clomipramine—Malaise—Prednisolone—chronic obstructive pulmonary disease	6.08e-05	0.00045	CcSEcCtD
Clomipramine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.05e-05	0.000448	CcSEcCtD
Clomipramine—Rash—Salbutamol—chronic obstructive pulmonary disease	6.05e-05	0.000447	CcSEcCtD
Clomipramine—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000447	CcSEcCtD
Clomipramine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.04e-05	0.000447	CcSEcCtD
Clomipramine—Nausea—Formoterol—chronic obstructive pulmonary disease	6.03e-05	0.000446	CcSEcCtD
Clomipramine—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.03e-05	0.000446	CcSEcCtD
Clomipramine—Headache—Salbutamol—chronic obstructive pulmonary disease	6.01e-05	0.000444	CcSEcCtD
Clomipramine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	5.96e-05	0.0177	CrCbGaD
Clomipramine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	5.93e-05	0.0176	CrCbGaD
Clomipramine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	5.92e-05	0.000438	CcSEcCtD
Clomipramine—Nausea—Montelukast—chronic obstructive pulmonary disease	5.91e-05	0.000437	CcSEcCtD
Clomipramine—Desipramine—HTR2A—chronic obstructive pulmonary disease	5.9e-05	0.0175	CrCbGaD
Clomipramine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	5.89e-05	0.0175	CrCbGaD
Clomipramine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	5.84e-05	0.000432	CcSEcCtD
Clomipramine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	5.82e-05	0.00043	CcSEcCtD
Clomipramine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000424	CcSEcCtD
Clomipramine—Promazine—HTR2A—chronic obstructive pulmonary disease	5.72e-05	0.0169	CrCbGaD
Clomipramine—Nausea—Salbutamol—chronic obstructive pulmonary disease	5.7e-05	0.000421	CcSEcCtD
Clomipramine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	5.67e-05	0.000419	CcSEcCtD
Clomipramine—Hallucination—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000414	CcSEcCtD
Clomipramine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	5.53e-05	0.000409	CcSEcCtD
Clomipramine—Oedema—Prednisolone—chronic obstructive pulmonary disease	5.5e-05	0.000407	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	5.5e-05	0.000407	CcSEcCtD
Clomipramine—Shock—Prednisolone—chronic obstructive pulmonary disease	5.41e-05	0.0004	CcSEcCtD
Clomipramine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	5.37e-05	0.000397	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.32e-05	0.000393	CcSEcCtD
Clomipramine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000389	CcSEcCtD
Clomipramine—Flushing—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000386	CcSEcCtD
Clomipramine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000378	CcSEcCtD
Clomipramine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000376	CcSEcCtD
Clomipramine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	5.03e-05	0.0149	CrCbGaD
Clomipramine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000372	CcSEcCtD
Clomipramine—Imipramine—HTR2A—chronic obstructive pulmonary disease	5e-05	0.0148	CrCbGaD
Clomipramine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	4.97e-05	0.000368	CcSEcCtD
Clomipramine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	4.97e-05	0.0147	CrCbGaD
Clomipramine—Alopecia—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000368	CcSEcCtD
Clomipramine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	4.94e-05	0.000365	CcSEcCtD
Clomipramine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.000365	CcSEcCtD
Clomipramine—Nortriptyline—ALB—chronic obstructive pulmonary disease	4.9e-05	0.0145	CrCbGaD
Clomipramine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	4.9e-05	0.000362	CcSEcCtD
Clomipramine—Pain—Prednisolone—chronic obstructive pulmonary disease	4.7e-05	0.000348	CcSEcCtD
Clomipramine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000341	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	4.54e-05	0.000336	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	4.53e-05	0.000335	CcSEcCtD
Clomipramine—Anaemia—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000335	CcSEcCtD
Clomipramine—Agitation—Prednisone—chronic obstructive pulmonary disease	4.5e-05	0.000333	CcSEcCtD
Clomipramine—Malaise—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000327	CcSEcCtD
Clomipramine—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000325	CcSEcCtD
Clomipramine—Syncope—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000325	CcSEcCtD
Clomipramine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.37e-05	0.000323	CcSEcCtD
Clomipramine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.000318	CcSEcCtD
Clomipramine—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.24e-05	0.000314	CcSEcCtD
Clomipramine—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000313	CcSEcCtD
Clomipramine—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000308	CcSEcCtD
Clomipramine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000308	CcSEcCtD
Clomipramine—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.15e-05	0.000307	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.000306	CcSEcCtD
Clomipramine—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.12e-05	0.000305	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.05e-05	0.0003	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000296	CcSEcCtD
Clomipramine—Oedema—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000296	CcSEcCtD
Clomipramine—Shock—Prednisone—chronic obstructive pulmonary disease	3.93e-05	0.000291	CcSEcCtD
Clomipramine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.00029	CcSEcCtD
Clomipramine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000289	CcSEcCtD
Clomipramine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3.88e-05	0.000287	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000286	CcSEcCtD
Clomipramine—Anorexia—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.000282	CcSEcCtD
Clomipramine—Diazepam—ALB—chronic obstructive pulmonary disease	3.71e-05	0.011	CrCbGaD
Clomipramine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000269	CcSEcCtD
Clomipramine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.000269	CcSEcCtD
Clomipramine—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000267	CcSEcCtD
Clomipramine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.59e-05	0.000265	CcSEcCtD
Clomipramine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.52e-05	0.00026	CcSEcCtD
Clomipramine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.000257	CcSEcCtD
Clomipramine—Rash—Prednisolone—chronic obstructive pulmonary disease	3.47e-05	0.000257	CcSEcCtD
Clomipramine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.46e-05	0.000256	CcSEcCtD
Clomipramine—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.45e-05	0.000255	CcSEcCtD
Clomipramine—Headache—Prednisolone—chronic obstructive pulmonary disease	3.45e-05	0.000255	CcSEcCtD
Clomipramine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	3.44e-05	0.0102	CrCbGaD
Clomipramine—Constipation—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000253	CcSEcCtD
Clomipramine—Amitriptyline—ALB—chronic obstructive pulmonary disease	3.4e-05	0.0101	CrCbGaD
Clomipramine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.29e-05	0.000244	CcSEcCtD
Clomipramine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000242	CcSEcCtD
Clomipramine—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.27e-05	0.000242	CcSEcCtD
Clomipramine—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.18e-05	0.000235	CcSEcCtD
Clomipramine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000234	CcSEcCtD
Clomipramine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000234	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000218	CcSEcCtD
Clomipramine—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000212	CcSEcCtD
Clomipramine—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.83e-05	0.000209	CcSEcCtD
Clomipramine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.73e-05	0.000202	CcSEcCtD
Clomipramine—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.64e-05	0.000196	CcSEcCtD
Clomipramine—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.54e-05	0.000188	CcSEcCtD
Clomipramine—Rash—Prednisone—chronic obstructive pulmonary disease	2.52e-05	0.000186	CcSEcCtD
Clomipramine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.52e-05	0.000186	CcSEcCtD
Clomipramine—Headache—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.000185	CcSEcCtD
Clomipramine—Nausea—Prednisone—chronic obstructive pulmonary disease	2.37e-05	0.000176	CcSEcCtD
Clomipramine—GSTP1—Metabolism—ALB—chronic obstructive pulmonary disease	1.41e-05	0.000285	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.000283	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.39e-05	0.000281	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000281	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000281	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.38e-05	0.00028	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.38e-05	0.00028	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.38e-05	0.000279	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.38e-05	0.000279	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.38e-05	0.000279	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.37e-05	0.000278	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.36e-05	0.000276	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.36e-05	0.000275	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000272	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.34e-05	0.000272	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.000267	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000266	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.28e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.28e-05	0.000259	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.28e-05	0.000259	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000258	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000257	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.27e-05	0.000256	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.000255	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.26e-05	0.000255	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.26e-05	0.000255	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.25e-05	0.000254	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000247	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.22e-05	0.000247	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.21e-05	0.000244	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.21e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000244	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.2e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.2e-05	0.000243	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000243	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.19e-05	0.00024	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.18e-05	0.000239	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.18e-05	0.000239	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.17e-05	0.000237	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.17e-05	0.000236	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.16e-05	0.000234	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000234	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.15e-05	0.000233	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.15e-05	0.000233	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000233	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.15e-05	0.000232	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.14e-05	0.000232	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.000231	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000228	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.12e-05	0.000227	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.12e-05	0.000226	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000224	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000223	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.1e-05	0.000222	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000222	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000222	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.09e-05	0.00022	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.08e-05	0.000219	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.08e-05	0.000219	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.07e-05	0.000217	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000216	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.000214	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.000211	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000208	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.03e-05	0.000208	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.02e-05	0.000206	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1e-05	0.000203	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.72e-06	0.000197	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.67e-06	0.000196	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.65e-06	0.000195	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.61e-06	0.000194	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.49e-06	0.000192	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.44e-06	0.000191	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.25e-06	0.000187	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.22e-06	0.000187	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.15e-06	0.000185	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.14e-06	0.000185	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.11e-06	0.000184	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.07e-06	0.000184	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.01e-06	0.000182	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	8.91e-06	0.00018	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.9e-06	0.00018	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.83e-06	0.000179	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.82e-06	0.000178	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.8e-06	0.000178	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.77e-06	0.000178	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.72e-06	0.000177	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.71e-06	0.000176	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.6e-06	0.000174	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.54e-06	0.000173	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.44e-06	0.000171	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.4e-06	0.00017	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.28e-06	0.000167	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.2e-06	0.000166	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	8.13e-06	0.000164	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.09e-06	0.000164	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.02e-06	0.000162	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	7.99e-06	0.000162	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.96e-06	0.000161	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.91e-06	0.00016	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.89e-06	0.00016	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.85e-06	0.000159	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.84e-06	0.000159	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.8e-06	0.000158	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.8e-06	0.000158	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.79e-06	0.000158	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.57e-06	0.000153	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.49e-06	0.000152	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.46e-06	0.000151	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.45e-06	0.000151	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.45e-06	0.000151	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.44e-06	0.000151	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.35e-06	0.000149	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.31e-06	0.000148	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.29e-06	0.000148	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.27e-06	0.000147	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.12e-06	0.000144	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.12e-06	0.000144	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.08e-06	0.000143	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.08e-06	0.000143	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.07e-06	0.000143	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.92e-06	0.00014	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.89e-06	0.000139	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.88e-06	0.000139	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.81e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.81e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.76e-06	0.000137	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.75e-06	0.000137	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.74e-06	0.000136	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.72e-06	0.000136	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.71e-06	0.000136	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.56e-06	0.000133	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.45e-06	0.000131	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.44e-06	0.00013	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.33e-06	0.000128	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.3e-06	0.000128	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.29e-06	0.000127	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.24e-06	0.000126	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.23e-06	0.000126	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.2e-06	0.000125	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.19e-06	0.000125	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.18e-06	0.000125	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.16e-06	0.000125	CbGpPWpGaD
Clomipramine—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.16e-06	0.000125	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.15e-06	0.000124	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.15e-06	0.000124	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.05e-06	0.000122	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	6.02e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.88e-06	0.000119	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.81e-06	0.000118	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.77e-06	0.000117	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.74e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.71e-06	0.000116	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.68e-06	0.000115	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.63e-06	0.000114	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.61e-06	0.000113	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.59e-06	0.000113	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.55e-06	0.000112	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.53e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.5e-06	0.000111	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.47e-06	0.000111	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.45e-06	0.00011	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.44e-06	0.00011	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.43e-06	0.00011	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.4e-06	0.000109	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.38e-06	0.000109	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.22e-06	0.000106	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.21e-06	0.000105	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.17e-06	0.000105	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.16e-06	0.000104	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.15e-06	0.000104	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-06	0.000103	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.03e-06	0.000102	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5e-06	0.000101	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.97e-06	0.000101	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.96e-06	0.0001	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.88e-06	9.88e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.86e-06	9.84e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.81e-06	9.73e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.77e-06	9.65e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	4.75e-06	9.61e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.74e-06	9.6e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.74e-06	9.59e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.72e-06	9.55e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	4.69e-06	9.48e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.64e-06	9.39e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.57e-06	9.25e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.52e-06	9.15e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.49e-06	9.09e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.48e-06	9.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.39e-06	8.88e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.37e-06	8.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.31e-06	8.73e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.31e-06	8.72e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.26e-06	8.62e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.24e-06	8.57e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.21e-06	8.52e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.18e-06	8.47e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.18e-06	8.45e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.12e-06	8.34e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.11e-06	8.32e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.04e-06	8.18e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.01e-06	8.12e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4e-06	8.1e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.93e-06	7.94e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.89e-06	7.87e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.81e-06	7.71e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.81e-06	7.7e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.81e-06	7.7e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.75e-06	7.58e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.65e-06	7.39e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.54e-06	7.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.51e-06	7.1e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.47e-06	7.03e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.42e-06	6.92e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.37e-06	6.82e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.32e-06	6.73e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.32e-06	6.73e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.32e-06	6.72e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.3e-06	6.69e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.24e-06	6.56e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.21e-06	6.5e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.2e-06	6.48e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-06	6.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.16e-06	6.4e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.14e-06	6.35e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.1e-06	6.27e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.1e-06	6.27e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.08e-06	6.22e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-06	6.18e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.01e-06	6.08e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.97e-06	6.01e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-06	5.94e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.93e-06	5.93e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-06	5.91e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.72e-06	5.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.7e-06	5.46e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.67e-06	5.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.59e-06	5.23e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.58e-06	5.23e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.48e-06	5.02e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.47e-06	5.01e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.43e-06	4.92e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.36e-06	4.78e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.24e-06	4.54e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.05e-06	4.15e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.04e-06	4.13e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2e-06	4.04e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	3.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.87e-06	3.78e-05	CbGpPWpGaD
